US08659B1026
US08659B1026
Beta Bionics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 100.251.000 | 65.124.000 | 53.9% |
| Cost of Revenue | 44.714.000 | 29.236.000 | 52.9% |
| Gross Profit | 55.537.000 | 35.888.000 | 54.8% |
| 127.218.000 | 81.139.000 | 56.8% | |
| Operating Income | -71.681.000 | -45.251.000 | 58.4% |
| Pretax Income | -73.200.000 | -54.756.000 | 33.7% |
| Net Income Common Stockholders | -73.200.000 | -54.756.000 | 33.7% |
| -- | -- | -- | |
| -- | -- | -- |